IP Library Granted Patent US 9,938,574
Granted Patent B2
US 9,938,574 · App. 14/439,859 · Granted Apr 10, 2018

Method and kit for detecting a wild-type and/or a mutated target DNA sequence

Inventors: Francesca Fontana (Bologna, IT); Nicolo Manaresi (Bologna, IT)
Assignee: Menarini Silicon Biosystems, S.p.A.
C12Q1/6874C12Q1/6806C12Q1/6855C12Q1/6858C12Q1/6886C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,574
App. No.
14/439,859
Granted
Apr 10, 2018
Kind
B2
Abstract

The present invention relates to a method for detecting a first and/or a second target DNA sequence from a DNA library, differing in that a mutation generates/eliminates a restriction site for a restriction endonuclease, comprising the steps of: (a) providing the DNA library, in which each of the DNA sequences comprises a first sequence segment, a second sequence segment of genomic DNA as cleaved by the restriction endonuclease, and a third sequence segment reverse complementary to the union of said first sequence segment and 5 ′ overhang, if any, of the restriction endonuclease; (b) amplifying the library of DNA sequences by PCR using: a first reverse primer which hybridizes to the 3′ end region of the second sequence segment of the first or second target sequence positive strand; a second forward primer which hybridizes to the 3′ end region of the second sequence segment of the first target sequence antipositive strand; a third forward primer comprising a first portion hybridizing to the 5′ end region of the third sequence segment of the second target sequence antipositive strand and a second portion hybridizing to the 3′ end region of the second sequence segment of the second target sequence antipositive strand, wherein the first portion of the third forward primer has a length from 20% to 80% with respect to the total length of the third forward primer; (c) detecting DNA sequences amplified in step (b).

Claims (17)

1. A method for detecting at least one of at least one first target DNA sequence and at least one second target DNA sequence from a library of DNA sequences, wherein the first target DNA sequence differs from the second target DNA sequence in that a single or multiple nucleotide substitution or deletion or insertion in the second target sequence generates a restriction site for a restriction endonuclease, giving rise—if cleaved by the restriction endonuclease—to a first cleaved second target sequence 3′ of the generated restriction site and a second cleaved second target sequence 5′ of the generated restriction site, comprising the steps of:

(a) providing the library of DNA sequences, each of the DNA sequences comprising, respectively from the 5′ end to the 3′ end, a first sequence segment having a length from 15 to 50 nucleotides, a second sequence segment of genomic DNA as cleaved by the restriction endonuclease, and a third sequence segment reverse complementary to the union of the first sequence segment and, if any, the 5′ overhang generated by the restriction endonuclease;

(b) amplifying the library of DNA sequences by PCR using:

at least one first reverse primer which hybridises to the 3′ end region of the second sequence segment of the at least one first target sequence positive strand or at least first cleaved second target sequence positive strand;

at least one second forward primer which hybridises to the 3′ end region of the second sequence segment of the at least one first target sequence antipositive strand;

at least one third forward primer comprising a first 5′ portion hybridising to the 5′ end region of the third sequence segment of the at least first cleaved second target sequence antipositive strand and a second 3′ portion hybridising to the 3′ end region of the second sequence segment of the at least one first cleaved second target sequence antipositive strand, wherein the first portion of the at least one third forward primer has a length from 20% to 80% with respect to the total length of the at least one third forward primer;

(c) detecting DNA sequences amplified in step (b).

2. The method according to claim 1 , wherein step (b) further uses at least one fourth reverse primer which hybridises to the 3′ end region of the second sequence segment of the at least one second target sequence positive strand.

3. The method according to claim 1 , wherein the library of DNA sequences is obtained by deterministic restriction site whole genome amplification.

4. The method according to claim 1 , wherein step (c) is performed by a DNA sequencing method.

5. The method according to claim 4 , wherein the DNA sequencing method is Sanger sequencing or sequencing by synthesis.

6. The method according to claim 1 , wherein the first portion of the at least one third forward primer has a length from 40% to 60% with respect to the total length of the at least one third forward primer.

7. The method according to claim 1 , wherein said second portion of the at least one third forward primer has a length in bases comprised between a minimum corresponding to the consensus sequence of said restriction endonuclease minus, if any, the 5′ overhang generated by the restriction endonuclease, all divided by two, and a maximum of 30 bases.

8. The method according to claim 1 , wherein at least one of said primers further comprises a 5′ end region which does not hybridize to any of said first or second target sequence, positive or antipositive strand.

9. The method according to claim 1 , wherein the restriction endonuclease is MseI.

10. A kit comprising a first, a second and a third primer according to claim 1 .

11. The kit according to claim 10 for use in the diagnosis of ALK or EGFR or PIK3CA mutations.

Assignments (2)
CHANGE OF NAME Recorded Aug 23, 2016
From: SILICON BIOSYSTEMS S.P.A
To: MENARINI SILICON BIOSYSTEMS S.P.A
Reel/Frame 039773/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2015
From: FONTANA, FRANCESCA; MANARESI, NICOLO
To: SILICON BIOSYSTEMS S.P.A.
Reel/Frame 036026/0574 →
Priority Claims (1)
IT TO2012A0962 · Oct 31, 2012 · national
Continuity (1)
Related Publication 20150368709A1 · Dec 24, 2015